MFC — Manulife Financial Corporation

Summary of Manulife Financial Corporation Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Core Earnings Growth: Manulife reported record core earnings with an 8% increase in core EPS year-over-year, reaching $1.5 billion in net income for the quarter.
• New Business CSM Growth: Achieved over 20% growth in new business CSM across all insurance segments, contributing to a double-digit increase in the CSM balance.
• Return on Equity (ROE): Core ROE expanded by 30 basis points to 17.1%, with a target of over 18% by 2027.
• Capital Management: Generated $6.4 billion in remittances and returned nearly $5.5 billion to shareholders, including a 10% increase in the quarterly dividend and a new NCIB program to repurchase up to 2.5% of outstanding shares.
• Balance Sheet Strength: Maintained a LICAT ratio of 136% and a leverage ratio of 23.9%, indicating strong financial flexibility.

2. Strategic Updates and Business Highlights

• Refreshed Enterprise Strategy: Announced a new strategy focused on being the #1 choice for customers, emphasizing growth through strategic investments, including acquisitions like Comvest Credit Partners and entering new markets such as India.
• AI Integration: Ranked 1st among global life insurers for AI maturity, with significant investments aimed at enhancing efficiency and customer experience through AI technologies.
• Product Innovations: Launched new offerings, including an indexed universal life product in the U.S. and a specialized lending suite in Canada, enhancing customer solutions.

3. Forward Guidance and Outlook

• 2026 Expectations: Management expressed confidence in achieving 2027 targets, with a focus on sustainable growth and capital efficiency.
• Market Positioning: Plans to continue share buybacks and maintain a balanced capital deployment strategy while investing in organic growth opportunities.

4. Bad News, Challenges, or Points of Concern

• Net Outflows in Global WAM: Experienced $9.5 billion in net outflows due to large retirement plan redemptions, which may impact future earnings.
• U.S. Claims Experience: Continued unfavorable mortality experience in the U.S. segment, with concerns about variability in claims impacting profitability.
• Hong Kong Sales Pressure: Noted a decline in sales due to regulatory changes affecting the broker channel, although core channels like agency and bancassurance performed well.
• Investment Performance: Reported a $232 million charge in the ALDA portfolio due to lower-than-expected returns from infrastructure, private equity, and real estate.

5. Notable Q&A Insights

• Hong Kong Sales Recovery: Management indicated confidence in a recovery in broker channel sales as distributors adjust to regulatory changes, supported by strong fundamentals in other distribution channels.
• U.S. Mortality Trends: Executives reassured that recent mortality variability is not indicative of a long-term trend, with expectations of normalization in claims experience.
• Capital Deployment Strategy: Emphasized a balanced approach to capital allocation, with a focus on maintaining excess capital for strategic flexibility while pursuing share buybacks.
• Private Equity and ALDA Concerns: Management addressed concerns regarding private equity performance, indicating strong credit experience and a diversified portfolio that mitigates risks.

Overall, Manulife demonstrated strong financial performance in 2025, with strategic initiatives aimed at long-term growth despite facing challenges in specific markets and segments.